Pulny testing announcement, the company's wholly-owned subsidiary Pulny Biomedical Technology (Shanghai) Co., Ltd. has received the "Drug GLP Certification Certificate" issued by the National Medical Products Administration. The acquisition of this certificate enables Pulny Shanghai Biomedical to have the capability to carry out drug non-clinical safety evaluation project certification, which is beneficial for undertaking the business of drug non-clinical safety evaluation and enhancing the one-stop CRO/CDMO service capability provided to pharmaceutical customers. Valid until October 27, 2029.